• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: LEICA BIOSYSTEMS MELBOURNE PTY. LTD. PELORIS RAPID TISSUE PROCESSOR; AUTOMATED TISSUE PROCESSOR,

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

LEICA BIOSYSTEMS MELBOURNE PTY. LTD. PELORIS RAPID TISSUE PROCESSOR; AUTOMATED TISSUE PROCESSOR, Back to Search Results
Model Number PELORIS
Device Problems Device Maintenance Issue (1379); Appropriate Term/Code Not Available (3191)
Patient Problems Tissue Damage (2104); Injury (2348)
Event Date 12/27/2016
Event Type  Injury  
Event Description
Leica biosystems received a complaint regarding sub-optimal tissue processing.On (b)(6) 2016, leica biosystems received the following information from the laboratory "there were two skin biopsies of suspected malignancies that were unreadable.They could not be re-biopsied since the original biopsy was the entire lesion.We had to sign the cases out with a disclaimer regarding suboptimal tissue processing.We could not make a definitive diagnosis in these 2 cases." patient information was not provided to leica biosystems, to date.Investigation of this complaint by leica biosystems is in progress and if additional information becomes available a follow up report will be submitted.
 
Event Description
The investigation by leica biosystems concluded that the processing reagent bottle concentration settings had been reset to the manufacturer default settings when a failed hard disk drive (hdd) was replaced by a leica field service engineer.The complainant's customized reagent bottle concentration settings specific to their processing protocol were not transferred over to the new hdd after the replacement was performed and thus led to the sub-optimal tissue processing.Information as to whether medical intervention was required to preclude permanent impairment of a body function or permanent damage to a body structure; and an identifier, gender and age or date of birth for each of the two (2) cases for which a definitive diagnosis could not be made, has been sought.If additional information becomes available another follow up report will be submitted.For additional information regarding the investigation and conclusion, please see manufacturer report 8020030-2017-00004 and follow up #01.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PELORIS RAPID TISSUE PROCESSOR
Type of Device
AUTOMATED TISSUE PROCESSOR,
Manufacturer (Section D)
LEICA BIOSYSTEMS MELBOURNE PTY. LTD.
495 blackburn road
mount waverley
victoria, 3149
AS  3149
MDR Report Key6267288
MDR Text Key65408343
Report Number1423337-2017-00001
Device Sequence Number1
Product Code IEO
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Distributor
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 02/10/2017,12/27/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/20/2017
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Other
Device Model NumberPELORIS
Device Catalogue Number26.0005
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? Yes
Date Report Sent to FDA02/10/2017
Distributor Facility Aware Date12/27/2016
Event Location Hospital
Date Report to Manufacturer02/10/2017
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage N
Patient Sequence Number1
Patient Outcome(s) Other;
-
-